Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1

Conditions

Lymphoma 204Lymphoma, Large B-Cell, Diffuse 168Precursor Cell Lymphoblastic Leukemia-Lymphoma 110Hodgkin Disease 85Lymphoma, Non-Hodgkin 79Burkitt Lymphoma 67Lymphoma, Follicular 62Leukemia 51Lymphoma, Mantle-Cell 48Lymphoma, B-Cell 33Lymphoma, Large-Cell, Anaplastic 31Lymphoma, T-Cell, Peripheral 27Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 25Lymphoma, Large-Cell, Immunoblastic 23Recurrence 20Lymphoma, B-Cell, Marginal Zone 17Leukemia, Lymphocytic, Chronic, B-Cell 17Immunoblastic Lymphadenopathy 17Lymphoma, T-Cell 16Neoplasms 14Dendritic Cell Sarcoma, Interdigitating 14Leukemia, Biphenotypic, Acute 10HIV Infections 10Enteropathy-Associated T-Cell Lymphoma 9Waldenstrom Macroglobulinemia 8Lymphoma, T-Cell, Cutaneous 8Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Lymphoma, Extranodal NK-T-Cell 7Cardiotoxicity 6

Interventions

Cyclophosphamide 8fludarabine 4Rituximab 4Melphalan 3tetulomab tetraxetan lu-177 2ponatinib 2fludarabine phosphate 2entrectinib 2atezolizumab 2alectinib 2Whole-Body Irradiation 2Vincristine 2Tacrolimus 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Lutetium 2Etoposide 2Doxorubicin 2Busulfan 2Brentuximab Vedotin 2Bortezomib 2Bone Marrow Transplantation 2trametinib 1pertuzumab 1penpulimab 1pembrolizumab 1ibritumomab tiuxetan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms by Histologic Type × Doxorubicin × Lymphoid × Clear all
NCT02855359 2019-03-11

Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Seagen Inc.

Phase 2 Terminated
24 enrolled 10 charts
Lymphoid

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00365274 2014-06-02

SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

National Cancer Institute (NCI)

Phase 2 Terminated
6 enrolled 3 charts
Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡